Fellowship in Maternal/Fetal Hematology
The Medical Disorders of Pregnancy Program at the University of Toronto is an internationally acknowledged program recognized for its excellence in patient care, medical education and research. This program, based predominantly at Mount Sinai Hospital in Toronto, exposes trainees to high patient volumes, a coordinated approach to patient management and research opportunities with world-class Maternal Fetal Medicine specialists.
This fellowship in Maternal/Fetal Hematology is intended for highly motivated academic physicians who have completed basic Hematology training and wish to pursue clinical and scholarly excellence in the approach and management of women with hematological disorders in pregnancy.
The Medical Disorders in Pregnancy Program at the University of Toronto provides a wide breadth of exposure to clinical hematological disorders peripartum including immune disorders, hemoglobinopathies, thromboembolism, myeloproliferative disorders, malignancies, and hemostasis as well as laboratory based exposure including the investigation and management of hemolytic disease of the fetus and newborn and fetal/neonatal alloimmune thrombocytopenia.
The fellow is strongly encouraged to enroll in a graduate program in research, medical education or quality improvement. The successful candidate will have at least 50% time dedicated to their academic activities. It is the intent of the fellowship that the successful candidate will become a future global leader in academic maternal/fetal hematology.
Duration: 2 years
Start date: from July 1, 2017
Interested hematology residents should submit their curriculum vitae, including the names of three referees, with a covering personal letter to Ms. Laurel Davis, Fellowship Coordinator for the Division of Hematology, University of Toronto, Toronto, Canada at firstname.lastname@example.org.
Disclaimer: The news stories shared on this site are used as a way to inform our members and followers of updates and relevant information happening in Haematology. The BSH does not endorse the content of news items from external sources, and is not in a position to verify the findings, accuracy or the source of any studies mentioned. Any medical or drugs information is provided as an information resource only, and is not to be relied on for any diagnostic or treatment purposes.